Meta-Analysis of the Efficacy and Safety of Genotype-Guided Strategy for Selection of P2Y12 Inhibitors in Coronary Artery Disease

Am J Cardiol. 2020 Dec 1:136:168-170. doi: 10.1016/j.amjcard.2020.09.023. Epub 2020 Sep 19.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Coronary Artery Disease / drug therapy*
  • Genotype
  • Humans
  • Purinergic P2Y Receptor Antagonists / adverse effects
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Treatment Outcome

Substances

  • Purinergic P2Y Receptor Antagonists